Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder.

Garlow SJ, Dunlop BW, Ninan PT, Nemeroff CB.

J Psychiatr Res. 2012 Nov;46(11):1406-13. doi: 10.1016/j.jpsychires.2012.08.009. Epub 2012 Sep 7.

2.

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.

Arch Gen Psychiatry. 2007 Jun;64(6):679-88.

PMID:
17548749
3.

Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL.

J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.

PMID:
21869699
4.

T3 augmentation of SSRI resistant depression.

Abraham G, Milev R, Stuart Lawson J.

J Affect Disord. 2006 Apr;91(2-3):211-5. Epub 2006 Feb 17.

PMID:
16483669
5.

Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.

Kasper S, Hajak G, Wulff K, Hoogendijk WJ, Montejo AL, Smeraldi E, Rybakowski JK, Quera-Salva MA, Wirz-Justice AM, Picarel-Blanchot F, Baylé FJ.

J Clin Psychiatry. 2010 Feb;71(2):109-20. doi: 10.4088/JCP.09m05347blu.

PMID:
20193645
6.

An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.

Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K; Sertraline Elderly Depression Study Group.

Am J Psychiatry. 2003 Jul;160(7):1277-85.

PMID:
12832242
7.

Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study.

Dunner DL, Amsterdam JD, Shelton RC, Loebel A, Romano SJ.

J Clin Psychiatry. 2007 Jul;68(7):1071-7.

PMID:
17685744
8.

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.

Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS.

JAMA. 2009 Oct 21;302(15):1651-7. doi: 10.1001/jama.2009.1487.

10.

Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.

Ventura D, Armstrong EP, Skrepnek GH, Haim Erder M.

Curr Med Res Opin. 2007 Feb;23(2):245-50.

PMID:
17288677
11.

Triiodothyronine addition to paroxetine in the treatment of major depressive disorder.

Appelhof BC, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Huyser J, Schene AH, Tijssen JG, Wiersinga WM.

J Clin Endocrinol Metab. 2004 Dec;89(12):6271-6.

PMID:
15579788
12.

A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.

Munizza C, Olivieri L, Di Loreto G, Dionisio P.

Curr Med Res Opin. 2006 Sep;22(9):1703-13.

PMID:
16968574
13.

The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial.

Schweizer E, Rynn M, Mandos LA, Demartinis N, García-España F, Rickels K.

Int Clin Psychopharmacol. 2001 May;16(3):137-43.

PMID:
11354235
14.
15.

Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, Carson WH, Adson D, Taylor L, Hazel J, Marcus RN.

CNS Spectr. 2009 Apr;14(4):197-206.

PMID:
19407731
16.

Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients?

Trivedi MH, Rush AJ, Carmody TJ, Donahue RM, Bolden-Watson C, Houser TL, Metz A.

J Clin Psychiatry. 2001 Oct;62(10):776-81.

PMID:
11816866
17.

Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression.

Murray V, von Arbin M, Bartfai A, Berggren AL, Landtblom AM, Lundmark J, Näsman P, Olsson JE, Samuelsson M, Terént A, Varelius R, Asberg M, Mårtensson B.

J Clin Psychiatry. 2005 Jun;66(6):708-16.

PMID:
15960563
18.

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.

Marcus RN, McQuade RD, Carson WH, Hennicken D, Fava M, Simon JS, Trivedi MH, Thase ME, Berman RM.

J Clin Psychopharmacol. 2008 Apr;28(2):156-65. doi: 10.1097/JCP.0b013e31816774f9.

PMID:
18344725
19.

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.

Hypericum Depression Trial Study Group.

JAMA. 2002 Apr 10;287(14):1807-14.

PMID:
11939866
20.

Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.

Perry EB, Berman RM, Sanacora G, Anand A, Lynch-Colonese K, Charney DS.

J Clin Psychiatry. 2004 Feb;65(2):238-43.

PMID:
15003079

Supplemental Content

Support Center